Margaret A. Tempero

1987–2024 年に発表

59
論文数
21,951
被引用数
50
h 指数
59
i10 指数

被引用数

Margaret A. Tempero の年別被引用数1986 年: 被引用 2 件1988 年: 被引用 1 件1989 年: 被引用 2 件1992 年: 被引用 2 件1994 年: 被引用 6 件1995 年: 被引用 8 件1996 年: 被引用 6 件1997 年: 被引用 7 件1998 年: 被引用 7 件1999 年: 被引用 6 件2000 年: 被引用 8 件2001 年: 被引用 13 件2002 年: 被引用 27 件2003 年: 被引用 32 件2004 年: 被引用 38 件2005 年: 被引用 39 件2006 年: 被引用 38 件2007 年: 被引用 41 件2008 年: 被引用 43 件2009 年: 被引用 21 件2010 年: 被引用 46 件2011 年: 被引用 53 件2012 年: 被引用 77 件2013 年: 被引用 82 件2014 年: 被引用 81 件2015 年: 被引用 176 件2016 年: 被引用 222 件2017 年: 被引用 250 件2018 年: 被引用 257 件2019 年: 被引用 848 件2020 年: 被引用 1,113 件2021 年: 被引用 1,114 件2022 年: 被引用 840 件2023 年: 被引用 618 件2024 年: 被引用 964 件2025 年: 被引用 451 件2026 年: 被引用 7 件1987 年は被引用が無いため表示していません1990〜1991 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,696 件、この内訳の 27%中国: 引用元論文 1,121 件、この内訳の 11.2%ドイツ: 引用元論文 660 件、この内訳の 6.6%イタリア: 引用元論文 606 件、この内訳の 6.1%イギリス: 引用元論文 584 件、この内訳の 5.8%日本: 引用元論文 461 件、この内訳の 4.6%カナダ: 引用元論文 395 件、この内訳の 3.9%フランス: 引用元論文 370 件、この内訳の 3.7%オランダ: 引用元論文 328 件、この内訳の 3.3%スペイン: 引用元論文 295 件、この内訳の 3%オーストラリア: 引用元論文 234 件、この内訳の 2.3%韓国: 引用元論文 224 件、この内訳の 2.2%
0%27%その他 20.3%

分野

  • Medicine72.1%
  • Biochemistry, Genetics and Molecular Biology19.8%
  • Immunology and Microbiology3.8%
  • Engineering1.6%
  • Materials Science0.9%
  • Computer Science0.4%
  • その他1.4%

トピック

  • Pancreatic and Hepatic Oncology Research17.6%
  • Cancer Genomics and Diagnostics5.4%
  • Cancer Cells and Metastasis3.4%
  • Venous Thromboembolism Diagnosis and Management3.2%
  • Cholangiocarcinoma and Gallbladder Cancer Studies3.1%
  • Cancer Immunotherapy and Biomarkers3%
  • その他64.3%

共著者

全論文

検索で開く
  1. Pancreatic cancer

    著者: , , , , , , , , , , - Nature Reviews Disease Primers 2016 被引用: 1,873

  2. Whole genomes redefine the mutational landscape of pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felicity Newell, Barsha Poudel, Sarah Song, Darrin F. Taylor, Nick M. Waddell, Scott Wood, Qinying Xu, Jianmin Wu, Mark Pinese, Mark J. Cowley, Hong C. Lee, Marc D. Jones, Adnan Nagrial, Jeremy L. Humphris, Lorraine A. Chantrill, Venessa Chin, Angela Steinmann, Amanda Mawson, Emily S. Humphrey, Emily K. Colvin, Angela Chou, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Pettitt, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Nigel B. Jamieson, Janet Graham, Simone P. Niclou, Rolf Bjerkvig, Robert Grützmann, Daniela E. Aust, Ralph H. Hruban, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Massimo Falconi, Giuseppe Zamboni, Giampaolo Tortora, Margaret A. Tempero, Anthony J. Gill, James R. Eshleman, Christian Pilarsky, Aldo Scarpa, Elizabeth A. Musgrove, John V. Pearson, Andrew V. Biankin, Sean M. Grimmond - Nature 2015 被引用: 2,709

  3. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

    著者: , , , , , , , , , , , , , , , , , - Nature Medicine 2011 被引用: 1,998

  4. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeanne Shen, Charles M. Vollmer, Robert A. Wolff, Brian M. Wolpin, Beth Lynn, Giby V. George - Journal of the National Comprehensive Cancer Network 2021 被引用: 1,286

  5. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 446

  6. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 1,475

  7. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 317

  8. Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J.S. Schuhbaur, Lukas Perkhofer, Margaret A. Tempero, Anke Reinacher‐Schick, Thomas J. Ettrich - Annals of Oncology 2022 被引用: 160

  9. Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michele Reni, Richard A. Epstein, Paul L. Vasey, Jeremy Shapiro, Matthew Burge, Yu Jo Chua, Marion Harris, Nick Pavlakis, Niall C. Tebbutt, Gerald W. Prager, Christian Dittrich, Friedrich Längle, Kathrin Philipp‐Abbrederis, Richard Greil, Herbert Stöger, Michael Girschikofsky, Thomas Kuehr, Jean–Luc Van Laethem, Stéphanie Laurent, Neesha C. Dhani, Yoo Joung Ko, Scot Dowden, Petr Kavan, Mustapha Édouard Tehfe, Eugen Kubala, Milan Kohoutek, Per Pfeiffer, Mette Yilmaz, Vibeke K. Parner, Tapio Salminen, Leena‐Maija Soveri, Eija Korkeila, Pia Österlund, Julien Taı̈eb, David Tougeron, Pascal Artru, François‐Xavier Caroli‐Bosc, Rosine Guimbaud, Antony Turpin, Thomas Walter, Jean‐Baptiste Bachet, Volker Kunzmann, Florian Kreth, Andreas De Block, Marino Venerito, Helmut Oettle, Meinolf Karthaus, Jörg Trojan, Gunnar Folprecht, Markus M. Lerch, Frank Kullmann, Marcel Reiser, Volker Heinemann, Marcus‐Alexander Wörns, H. Schulz, Benjamin Garlipp, Thomas Yau, Lam Stephen Chan, Balázs Juhász, László Landherr, Tamás Pintér, G. Bodoky, Zsuzsanna Kahán, Raymond McDermott, Derek G. Power, Luca Gianni, Salvatore Siena, Michèle Milella, Alfredo Falcone, Rossana Berardi ほか 87 名 - Journal of Clinical Oncology 2022 被引用: 132

  10. Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 被引用: 162

  11. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah P. Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2017 被引用: 1,030

  12. Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer

    著者: , , , , , , , , , , , , , , , , , - Cancer Discovery 2015 被引用: 486

  13. Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 152

  14. Discovering dominant tumor immune archetypes in a pan-cancer census

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evans Shao, Darrell Abrau, Leonard Lupin, Cole Shaw, Zachary Collins, Tasha Lea, Carlos U. Corvera, Eric K. Nakakura, Julia Carnevale, Michael Alvarado, Kimberley Loo, Lawrence Chen, Melissa Chow, Jennifer R. Grandis, Will G. Ryan, Ivan H. El‐Sayed, David M. Jablons, Gavitt A. Woodard, Maxwell W. Meng, Sima P. Porten, Hideho Okada, Margaret A. Tempero, Andrew H. Ko, Kim Kirkwood, Scott Vandenberg, Denise Guevarra, Erica Oropeza, C. St. Cyr, Pat Glenn, Jennifer Bolen, Amanda Morton, Walter L. Eckalbar, Cathy Cai, Jenny Zhan, Katelyn C. Davis, Robin Kate Kelley, Jocelyn Chapman, Chloé E. Atreya, Amar Patel, Adil Daud, Patrick K. Ha, Aarón Díaz, Johannes R. Kratz, Eric A. Collisson, Gabriela K. Fragiadakis, David J. Erle, Alexandre Boissonnas, Saurabh Asthana, Vincent Chan, Matthew F. Krummel - Cell 2021 被引用: 176

  15. NCCN Guidelines Updates: Pancreatic Cancer.

    著者: - 2019 被引用: 327

  16. A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma

    著者: , , , , , , , , , , , - Pancreas 2015 被引用: 221

  17. HALO-109–301: a Phase III trial of PEGPH20 (with Pemcitabine and Nab-Paclitaxel) in Hyaluronic Acid-High Stage IV Pancreatic Cancer

    著者: , , - Future Oncology 2017 被引用: 155

  18. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 被引用: 135

  19. Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

    著者: , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 114

  20. Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah P. Thayer, Robert A. Wolff, Jennifer L. Burns, Griselda Zuccarino-Catania - Journal of the National Comprehensive Cancer Network 2019 被引用: 371

  21. HALO 109-301: A randomized, double-blind, placebo-controlled, phase 3 study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients (pts) with previously untreated hyaluronan (HA)-high metastatic pancreatic ductal adenocarcinoma (mPDA).

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 114

  22. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.

    著者: , , , , , - 1987 被引用: 402

  23. Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , - Molecular Therapy 2020 被引用: 56

  24. Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas

    著者: , , , , , , , , , , , , , , , , - Cancer Discovery 2015 被引用: 284